Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07735234
NA

Tolerability of Transcutaneous Vagal Nerve Stimulation

Sponsor: The University of Texas Health Science Center, Houston

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the feasibility and tolerability of transcutaneous auricular vagus nerve stimulation (taVNS) in childhood stroke survivors undergoing bi-manual occupational therapy.

Official title: Tolerability of Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Stroke Survivors 1Tolerability of Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Stroke Survivors 1

Key Details

Gender

All

Age Range

13 Years - 21 Years

Study Type

INTERVENTIONAL

Enrollment

1

Start Date

2026-07-30

Completion Date

2026-09-04

Last Updated

2026-07-29

Healthy Volunteers

No

Conditions

Interventions

DEVICE

transcutaneous auricular vagus nerve stimulation (taVNS)

The participant will undergo 2-hour therapy sessions, 3 times per week, for 4 weeks for a total of 12 occupational therapy sessions with stimulation after the visit. Participants will receive 90 minutes of therapy per session. Stimulation will be delivered using a biphasic rectangular pulse, pulse width of 250 us, frequency of 25Hz, duty cycle of 30 seconds on / 30 seconds off during active therapy. 1 second ramp up and ramp down will be used to improve comfort. Maximum total stimulation per session will not exceed 45 minutes.

Locations (1)

The University of Texas Health Science Center at Houston

Houston, Texas, United States